{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-038757","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.226858+00:00","generated_at":"2026-05-24T21:34:47.421166+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Candel Therapeutics reports positive phase 3 CAN-2409 data in prostate cancer; cash runway into Q1 2027","bullets":["Positive phase 3 results for CAN-2409 in prostate cancer: 30% risk reduction, 80.4% pathological complete responses; BLA submission expected Q4 2026.","Phase 2a pancreatic cancer: median OS 31.4 months (CAN-2409) vs 12.5 months (control); long-term survivors.","Cash and cash equivalents $102.7M as of Dec 31, 2024; sufficient into Q1 2027.","Net loss for full year 2024: $55.2M; R&D expenses decreased to $19.3M from $24.5M.","Upcoming milestones: NSCLC final OS data Q1 2025; CAN-3110 data Q4 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-038757","json":"https://secwatch.observer/filing/0000950170-25-038757.json","markdown":"https://secwatch.observer/filing/0000950170-25-038757.md","text":"https://secwatch.observer/filing/0000950170-25-038757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000095017025038757/0000950170-25-038757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000095017025038757/cadl-20250313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:34:47.421166+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}